Literature DB >> 19074894

Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells.

Huey-Jen L Lin1, Tao Zuo, Ching-Hung Lin, Chieh Ti Kuo, Sandya Liyanarachchi, Shuying Sun, Rulong Shen, Daniel E Deatherage, Dustin Potter, Lisa Asamoto, Shili Lin, Pearlly S Yan, Ann-Lii Cheng, Michael C Ostrowski, Tim H-M Huang.   

Abstract

The interplay between histone modifications and promoter hypermethylation provides a causative explanation for epigenetic gene silencing in cancer. Less is known about the upstream initiators that direct this process. Here, we report that the Cystatin M (CST6) tumor suppressor gene is concurrently down-regulated with other loci in breast epithelial cells cocultured with cancer-associated fibroblasts (CAF). Promoter hypermethylation of CST6 is associated with aberrant AKT1 activation in epithelial cells, as well as the disabled INNP4B regulator resulting from the suppression by CAFs. Repressive chromatin, marked by trimethyl-H3K27 and dimethyl-H3K9, and de novo DNA methylation is established at the promoter. The findings suggest that microenvironmental stimuli are triggers in this epigenetic cascade, leading to the long-term silencing of CST6 in breast tumors. Our present findings implicate a causal mechanism defining how tumor stromal fibroblasts support neoplastic progression by manipulating the epigenome of mammary epithelial cells. The result also highlights the importance of direct cell-cell contact between epithelial cells and the surrounding fibroblasts that confer this epigenetic perturbation. Because this two-way interaction is anticipated, the described coculture system can be used to determine the effect of epithelial factors on fibroblasts in future studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074894      PMCID: PMC2821873          DOI: 10.1158/0008-5472.CAN-08-0288

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.

Authors:  M P Shekhar; J Werdell; S J Santner; R J Pauley; L Tait
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 3.  An epigenetic road map for histone lysine methylation.

Authors:  Monika Lachner; Roderick J O'Sullivan; Thomas Jenuwein
Journal:  J Cell Sci       Date:  2003-06-01       Impact factor: 5.285

Review 4.  DNA methylation and histone modifications: teaming up to silence genes.

Authors:  François Fuks
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 5.  Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis.

Authors:  Jong B Kim; Robert Stein; Mike J O'Hare
Journal:  Tumour Biol       Date:  2005-07-06

6.  Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance.

Authors:  Mingqiang Ren; Silvia Pozzi; Gaia Bistulfi; Giulia Somenzi; Stefano Rossetti; Nicoletta Sacchi
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 7.  Perturbations of the AKT signaling pathway in human cancer.

Authors:  Deborah A Altomare; Joseph R Testa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

8.  Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene.

Authors:  S Barnache; E Le Scolan; O Kosmider; N Denis; F Moreau-Gachelin
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

9.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters.

Authors:  Alfred S L Cheng; Victor X Jin; Meiyun Fan; Laura T Smith; Sandya Liyanarachchi; Pearlly S Yan; Yu-Wei Leu; Michael W Y Chan; Christoph Plass; Kenneth P Nephew; Ramana V Davuluri; Tim H-M Huang
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

10.  The Polycomb group protein EZH2 directly controls DNA methylation.

Authors:  Emmanuelle Viré; Carmen Brenner; Rachel Deplus; Loïc Blanchon; Mario Fraga; Céline Didelot; Lluis Morey; Aleyde Van Eynde; David Bernard; Jean-Marie Vanderwinden; Mathieu Bollen; Manel Esteller; Luciano Di Croce; Yvan de Launoit; François Fuks
Journal:  Nature       Date:  2005-12-14       Impact factor: 49.962

View more
  40 in total

1.  IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.

Authors:  Yinu Wang; Xingyue Zong; Sumegha Mitra; Anirban Kumar Mitra; Daniela Matei; Kenneth P Nephew
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Methods in DNA methylation profiling.

Authors:  Tao Zuo; Benjamin Tycko; Ta-Ming Liu; Juey-Jen L Lin; Tim H-M Huang
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

Review 3.  Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

Authors:  Amy M Dworkin; Tim H-M Huang; Amanda Ewart Toland
Journal:  Semin Cancer Biol       Date:  2009-02-20       Impact factor: 15.707

Review 4.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 5.  Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

Authors:  Tamas A Gonda; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Semin Cell Dev Biol       Date:  2009-10-17       Impact factor: 7.727

6.  Drug-loaded biodegradable microspheres for image-guided combinatory epigenetic therapy in cells.

Authors:  Ronald X Xu; Jeff S Xu; Tao Zuo; Rulong Shen; Tim H Huang; Michael F Tweedle
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

7.  Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Authors:  Jing-Zhe Sun; Xue-Xi Yang; Xiang-Hong Li; Wei-Wen Xu; Ying Wang; Wei Zhu; Ming Li
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

Review 8.  Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Authors:  Martin Widschwendter; Allison Jones; Iona Evans; Daniel Reisel; Joakim Dillner; Karin Sundström; Ewout W Steyerberg; Yvonne Vergouwe; Odette Wegwarth; Felix G Rebitschek; Uwe Siebert; Gaby Sroczynski; Inez D de Beaufort; Ineke Bolt; David Cibula; Michal Zikan; Line Bjørge; Nicoletta Colombo; Nadia Harbeck; Frank Dudbridge; Anne-Marie Tasse; Bartha M Knoppers; Yann Joly; Andrew E Teschendorff; Nora Pashayan
Journal:  Nat Rev Clin Oncol       Date:  2018-02-27       Impact factor: 66.675

9.  Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.

Authors:  Yi-Wen Huang; Joseph C Liu; Daniel E Deatherage; Jingqin Luo; David G Mutch; Paul J Goodfellow; David S Miller; Tim H-M Huang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

10.  Identifying differentially methylated genes using mixed effect and generalized least square models.

Authors:  Shuying Sun; Pearlly S Yan; Tim H M Huang; Shili Lin
Journal:  BMC Bioinformatics       Date:  2009-12-09       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.